| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701799 | Journal of Thoracic Oncology | 2017 | 12 Pages |
Abstract
We showed that BAP1 protein determination is a diagnostic tool to correctly distinguish biphasic MPM from epithelial subtypes with an atypical/activated reactive stroma and an independent prognostic parameter in MPM.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Luisella MD, PhD, Eleonora MD, PhD, Simona BSc, Stefania MLT, Jessica MLT, Milena BSc, PhD, Valeria MD, Enrico MD, Laura MD, Marco MD, Mauro MD, Giorgio Vittorio MD,